Search research articles
Contact Us
Filters
Showing results (631-640 of 1,376) with videos related to
Page
of 138
Sort By:
Virology
|
March 23, 2010
Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms
Devon J Shedlock, Michael A Bailey, Paul M Popernack, et al.
Aging Cell
|
August 18, 2022
B cell-intrinsic changes with age do not impact antibody-secreting cell formation but delay B cell participation in the germinal centre reaction
Jia Le Lee, Sigrid C Fra-Bido, Alice R Burton, et al.
Journal of Robotic Surgery
|
March 30, 2024
Emerging multi-port soft tissue robotic systems: a systematic review of clinical outcomes
Yit J Leang, Joseph C H Kong, Zahin Mosharaf, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
June 12, 2009
Medium-term outcome of fundoplication after lung transplantation
P R Burton, B Button, W Brown, et al.
Journal of Virology
|
August 13, 2010
Very few substitutions in a germ line antibody are required to initiate significant domain exchange
Michael Huber, Khoa M Le, Katie J Doores, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 30, 2010
Central nervous system destruction mediated by glutamic acid decarboxylase-specific CD4+ T cells
Amanda R Burton, Zachary Baquet, George S Eisenbarth, et al.
Immunology Letters
|
July 1, 1997
Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design"
P W Parren, M C Gauduin, R A Koup, et al.
Immunity
|
October 13, 2009
T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event
Greig P Lennon, Maria Bettini, Amanda R Burton, et al.
The Journal of Experimental Medicine
|
October 23, 1997
Inhibition of virus attachment to CD4+ target cells is a major mechanism of T cell line-adapted HIV-1 neutralization
S Ugolini, I Mondor, P W Parren, et al.
Journal of Virology
|
July 11, 1998
Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodies
N Sullivan, Y Sun, J Binley, et al.
Page
of 138
Search research articles
Search
Showing results (631-640 of 1,376) with videos related to
Sort By:
Page
of 138
Virology
|
March 23, 2010
Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms
Devon J Shedlock, Michael A Bailey, Paul M Popernack, et al.
Aging Cell
|
August 18, 2022
B cell-intrinsic changes with age do not impact antibody-secreting cell formation but delay B cell participation in the germinal centre reaction
Jia Le Lee, Sigrid C Fra-Bido, Alice R Burton, et al.
Journal of Robotic Surgery
|
March 30, 2024
Emerging multi-port soft tissue robotic systems: a systematic review of clinical outcomes
Yit J Leang, Joseph C H Kong, Zahin Mosharaf, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
June 12, 2009
Medium-term outcome of fundoplication after lung transplantation
P R Burton, B Button, W Brown, et al.
Journal of Virology
|
August 13, 2010
Very few substitutions in a germ line antibody are required to initiate significant domain exchange
Michael Huber, Khoa M Le, Katie J Doores, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 30, 2010
Central nervous system destruction mediated by glutamic acid decarboxylase-specific CD4+ T cells
Amanda R Burton, Zachary Baquet, George S Eisenbarth, et al.
Immunology Letters
|
July 1, 1997
Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design"
P W Parren, M C Gauduin, R A Koup, et al.
Immunity
|
October 13, 2009
T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event
Greig P Lennon, Maria Bettini, Amanda R Burton, et al.
The Journal of Experimental Medicine
|
October 23, 1997
Inhibition of virus attachment to CD4+ target cells is a major mechanism of T cell line-adapted HIV-1 neutralization
S Ugolini, I Mondor, P W Parren, et al.
Journal of Virology
|
July 11, 1998
Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodies
N Sullivan, Y Sun, J Binley, et al.
Page
of 138